Risk Of Distant Recurrence Of ER-Positive Breast Cancer In Premenopausal Women According To 70-Gene Risk Signature

Published by W Butcher on

Long-term 20-year follow-up of premenopausal patients with oestrogen receptor (ER)-positive breast cancer and stratification by the 70-gene Risk Signature suggested that patients at high risk of distant disease recurrence derive significant benefit from goserelin, while patients at low risk have greater benefit with tamoxifen. These findings were presented at the ESMO Breast Cancer Virtual Congress 2021, held 5 to 8 May 2021.

Read More…

Categories: Uncategorized